INS and diabetic ketoacidosis: Globally, an increase of 0.26% in ASMR highlighted the shortcomings in prevention and control in low- and middle-income countries, such as the insufficient availability of insulin in sub-Saharan Africa, resulting in a mortality rate of diabetic ketoacidosis 4.7 times higher than that in high-income regions [1, 9].